Antimicrobial prescribing: Ceftazidime/avibactam

This evidence summary outlines the best available evidence for a new intravenous antimicrobial, ceftazidime/avibactam (Zavicefta). It is indicated for treating complicated intra-abdominal infections,complicated urinary tract infections, including pyelonephritis,hospital ‑acquired pneumonia, including ventilator‑associated pneumonia and infections caused by aerobic gram‑negative organisms in adults with limited treatment options.
Source: Current Awareness Service for Health (CASH) - Category: Consumer Health News Source Type: news